stockrow
Saturday 7 November 2026
Export MVIS’s income statement to Excel — free account
Microvision, Inc.
MVIS Technology Scientific & Technical Instruments
Microvision, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 million, down 74.3% from fiscal 2024.
- Revenue
- +895.9%
- EPS
- +40.0%
- Free cash flow
- +9.71%
- Total debt
- −54.8%
Quarter to September 2026, against a year earlier
1.16
0.02
+1.75%
Follow MVIS
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
8.17 | 38.04 | 127.44 | 187.31 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(3.01) | (5.71) | (12.04) | (14.69) | |
P/B ratio |
1.81 | 5.30 | 5.01 | 4.07 | |
Price to Tangible BV |
7.19 | 33.53 | 8.92 | 4.08 | |
EV/Sales |
2.38 | 28.41 | 97.47 | 124.98 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(0.18) | (1.21) | (2.48) | (2.57) | |
EV/FCF |
(0.18) | (1.19) | (2.45) | (2.54) | |
Quick Ratio |
0.65 | 0.57 | 0.91 | 2.50 | |
Current Ratio |
0.80 | 0.68 | 1.05 | 2.69 | |
Net Debt/EBITDA |
1.76 | 1.76 | 2.53 | 2.75 | |
Debt/Assets |
0.02% | 0.02% | 0.02% | 0.03% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.04 | 0.03 | 0.01 | 0.01 | |
Operating CF/Net income |
1.12 | 0.52 | 0.65 | 0.41 | |
Capex/Depreciation |
(0.28) | (0.04) | (0.03) | (0.02) | |
Interest Coverage |
(11.19) | (4.42) | (8.53) | (32.84) | |
Research and Development Expense of Revenue |
549.17% | 1,065.99% | 1,544.92% | 3,892.83% | |
Selling, General and Administrative Expense of Revenue |
389.96% | 625.32% | 1,017.22% | 1,428.25% | |
Intangible Assets out of Total Assets |
0.19 | 0.20 | 0.16 | 0.00 | |
Share Based Compensation of Revenue |
48.42% | 88.53% | 105.13% | (693.72%) | |
Graham Net Nets |
(0.74) | (0.31) | (0.08) | 0.15 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(340.57%) | (110.37%) | (48.31%) | (42.25%) | |
Free Cash Flow Yield |
(162.33%) | (62.52%) | (31.20%) | (26.25%) | |
Revenue per Share |
0.09 | 0.07 | 0.05 | 0.01 | |
Operating CF per Share |
(0.50) | (0.86) | (0.80) | (0.85) | |
Capex per Share |
(0.05) | (0.01) | (0.01) | (0.01) | |
Free Cash Flow per Share |
(0.55) | (0.87) | (0.81) | (0.86) | |
Cash per Share |
1.06 | 1.24 | 2.26 | 4.13 | |
Shareholders Equity per Share |
0.83 | 0.92 | 1.92 | 3.05 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.83 | 0.92 | 1.92 | 3.05 | |
Free Cash Flow |
(15.00) | (19.45) | (16.59) | (15.65) | |
Working Capital |
(9.29) | (16.14) | 2.46 | 50.96 | |
Capital Expenditures |
(1.37) | (0.30) | (0.14) | (0.24) | |
Net Current Asset Value |
(30.23) | (33.70) | (16.44) | 33.54 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.57 | 0.21 | 0.15 | 1.09 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.72 | 0.51 | 0.49 | 0.49 | |
Average Payables |
3.85 | 3.72 | 2.90 | 1.38 | |
Average Inventory |
6.27 | 4.89 | 3.28 | 1.52 | |
Average Assets |
120.83 | 114.61 | 113.47 | 112.14 | |
Average Common Equity |
56.73 | 48.86 | 46.37 | 52.16 |
Columns are period end dates · fundamentals updated 6 Nov 2026